Gachon Neuroscience Research Institute
- Gachon Neuroscience Research Institute
- Major co-development institutes
Siemens (Germany), Harvard Medical School and others
- Area of current development
PET-MRI Fusion Imaging System
- Critical Technology of GNRI
- High-resolution image latest algorithm
- Development of Core MRI parts
LEE GIL YA Cancer and Diabetes Institute
- Major Research Centers
- Diabetes & Metabolic Disease Research Center
- Cancer Research Center
- Center for Regenerative Medicine
- The Korea Mouse Metabolic Phenotyping Center
- Center for Genomics and Proteomics
- Goal
Continued study regarding cancer, diabetes mellitus, obesity and
inflammatory diseases - Critical Technology of CDI
- Human Genome analysis, 5th in the world
- Development of new contrast agent for MRI
Bio Research Complex
- Scale : 205,793 ㎡
- Manage overall process of clinical development, manufacture
facilities, administration, and academic exchange programs - Master Plan
- Build Cutting-edge BINT Cluster
- Place for complex task & academic tie
- Basis for research production
- Neuroscience Research Institute
- Founded in 2004
- Initial Investment : 64 billion won
- Infrastructure for superior clinical imaging system
- Gil Medical Center
- 12 specialized centers
- Brain and metabolic disease-specialized clinic and research capacity
- Gil medical center affiliated NRI and LCDI
- Lee Gil Ya Cancer and Diabetes Institute
- Founded in 2008
- Initial Investment : 67 billion won
- Infrastructure for cancer and metabolic disease research
-
Open research resources in NRI
- Super resolution imaging system (7T MRI, HRRTPET)
- Fusion imaging system with improved accuracy and precision
- Early diagnosis for nuerodegenerative diseases (Alzheimer’s and Parkinson’s disease) and stroke
- Medical System Twinning project
- Technology transfer between Gil-medical center and Daewong pharmaceutical for cancer MRI
Goal
- IND approval in a year
- Phase 1 entry in 2 years
- Open research resources in LCDI
- Fully equipped facilities specialized to cancer and diabetes
- KMMPC: First mouse metabolic phenotyping center in Asia
- NECMD: Efficacy evaluation center for metabolic drugs
- One stop/Conveyer system optimized for efficacy evaluation of metabolic disease therapeutics(https://www.necmd.co.kr)
- Genetically engineered mouse phenotyping for efficacy evaluation of metablic disease therapeutics